Edward Li publishes papers on biosimilars, referenced in 'Pharmacy Times'

Edward C. Li, Pharm.D., M.P.H., BCOP, associate professor in the College of Pharmacy, recently published several papers on the growing global interest of biosimilar products in the health care community. His latest paper, “Pharmacist Substitution of Biological Products: Issues and Considerations,” was published in the July 2015 edition of the Journal of Managed Care & Specialty Pharmacy, and was referenced in a Pharmacy Times article.

In his paper, Li outlines why it is important for pharmacists and the community to be aware of the differences between generic and biosimilar medication, which are similar but not identical to brand-name medications. He explains that pharmacists need to be knowledgeable about specific state-requirements regarding the dispensing of biosimilars in pharmacy settings.

Li also recently discussed biosimilars in two other published papers:

• “Considerations in the Early Development of Biosimilar Products,” published in the May 2015 issue of Drug Discovery Today.
• “Development of Biosimilars in an Era of Oncologic Drug Shortages,” published in Volume 9, 2015 of Drug Design, Development and Therapy.